Trades on 1 secondary market

Rondo Therapeutics

Rondo Therapeutics is a clinical-stage biotechnology company based in Hayward, California, developing immune-cell engaging bispecific antibodies designed to treat solid tumors by unleashing the immune system while maximizing efficacy and minimizing side effects. Founded in 2019 by Shelley Force Aldr

minimal 11.0 / 100 0 APIs View provider profile →
CompanyBiotechnologyTherapeuticsOncologyAntibodiesImmunotherapy

Rondo Therapeutics is an API provider whose private shares are listed on 1 secondary market: Nasdaq Private Market.

Where It Trades

N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.